325 related articles for article (PubMed ID: 6333947)
1. The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigen.
Ziegler-Heitbrock HW; Fütterer A; Rumpold H; Kraft D; Munker R; Riethmüller G
Clin Exp Immunol; 1984 Nov; 58(2):470-7. PubMed ID: 6333947
[TBL] [Abstract][Full Text] [Related]
2. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes.
Rumpold H; Kraft D; Obexer G; Böck G; Gebhart W
J Immunol; 1982 Oct; 129(4):1458-64. PubMed ID: 6180009
[TBL] [Abstract][Full Text] [Related]
4. The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killing.
Rumpold H; Kraft D; Gastl G; Huber C
Clin Exp Immunol; 1984 Sep; 57(3):703-9. PubMed ID: 6467685
[TBL] [Abstract][Full Text] [Related]
5. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
6. A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8.
Perussia B; Fanning V; Trinchieri G
J Immunol; 1983 Jul; 131(1):223-31. PubMed ID: 6408172
[TBL] [Abstract][Full Text] [Related]
7. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
Dato ME; Kim YB
J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
[TBL] [Abstract][Full Text] [Related]
8. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
9. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
10. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
11. The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.
Freundlich B; Trinchieri G; Perussia B; Zurier RB
J Immunol; 1984 Mar; 132(3):1255-60. PubMed ID: 6693767
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody (VEP10) against an antigen shared by human large granular lymphocytes, thymocytes and activated T cells.
Rumpold H; Kraft D; Obexer G; Böck G; Möschl P
Immunology; 1983 Jun; 49(2):265-72. PubMed ID: 6602090
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
Bonavida B; Lebow LT; Bradley TP
J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
[TBL] [Abstract][Full Text] [Related]
14. A study of GRM1 monoclonal antibody that reacts with natural killer cells and granulocytes.
Ruiz-Cabello F; López Nevot MA; Garrido A; Garrido F
Nat Immun Cell Growth Regul; 1987; 6(2):99-108. PubMed ID: 2439907
[TBL] [Abstract][Full Text] [Related]
15. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells inhibit outgrowth of autologous Epstein-Barr virus-infected B lymphocytes.
Kaplan J; Shope TC
Nat Immun Cell Growth Regul; 1985; 4(1):40-7. PubMed ID: 2993873
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
[TBL] [Abstract][Full Text] [Related]
18. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
[TBL] [Abstract][Full Text] [Related]
20. Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures.
Strassmann G; Bach FH; Zarling JM
J Immunol; 1983 Apr; 130(4):1556-60. PubMed ID: 6220056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]